NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

One of the biggest stories of last week was how West Pharmaceutical Services, Inc. (NYSE:WST) shares plunged 33% in the week since its latest full-year results, closing yesterday at US$215.

The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently ...

In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against other last week’s worst performers. Ten companies posted double-digit declines ...

West Pharmaceutical Services has a 52-week low of $197.01 and a 52-week high of $400.88. West Pharmaceutical Services ( NYSE:WST – Get Free Report ) last posted its earnings results on Thursday ...

One of the biggest stories of last week was how West Pharmaceutical Services, Inc. (NYSE:WST) shares plunged 33% in the week since its latest full-year results, closing yesterday at US$215. West ...

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against other ...

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East ...

Our vision for our lead asset NOX-A12 remains clear: to secure approval for its use in glioblastoma patients through a strategic partnership with a pharmaceutical company, supported by ...